These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 35401175)

  • 1. The Botanical Drug PBI-05204, a Supercritical CO
    Colapietro A; Yang P; Rossetti A; Mancini A; Vitale F; Chakraborty S; Martellucci S; Marampon F; Mattei V; Gravina GL; Iorio R; Newman RA; Festuccia C
    Front Pharmacol; 2022; 13():852941. PubMed ID: 35401175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Botanical Drug PBI-05204, a Supercritical CO
    Colapietro A; Yang P; Rossetti A; Mancini A; Vitale F; Martellucci S; Conway TL; Chakraborty S; Marampon F; Mattei V; Gravina GL; Biordi AL; Wei D; Newman RA; Festuccia C
    Front Pharmacol; 2020; 11():552428. PubMed ID: 33013390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PBI-05204, a supercritical CO
    Chakraborty S; Wei D; Tran M; Lang FF; Newman RA; Yang P
    Neoplasia; 2024 Aug; 54():101008. PubMed ID: 38823209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The botanical drug PBI-05204, a supercritical CO
    Vaccaro S; Rossetti A; Porrazzo A; Camero S; Cassandri M; Pomella S; Tomaciello M; Macioce G; Pedini F; Barillari G; Marchese C; Rota R; Cenci G; Tombolini M; Newman RA; Yang P; Codenotti S; Fanzani A; Megiorni F; Festuccia C; Minniti G; Gravina GL; Vulcano F; Milazzo L; Marampon F
    Front Pharmacol; 2022; 13():1071176. PubMed ID: 36532747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: The Botanical Drug PBI-05204, a Supercritical CO
    Frontiers Production Office
    Front Pharmacol; 2022; 13():937601. PubMed ID: 35707399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo neuroprotective activity of the cardiac glycoside oleandrin from Nerium oleander in brain slice-based stroke models.
    Dunn DE; He DN; Yang P; Johansen M; Newman RA; Lo DC
    J Neurochem; 2011 Nov; 119(4):805-14. PubMed ID: 21950737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PBI-05204, a supercritical CO₂ extract of Nerium oleander, inhibits growth of human pancreatic cancer via targeting the PI3K/mTOR pathway.
    Pan Y; Rhea P; Tan L; Cartwright C; Lee HJ; Ravoori MK; Addington C; Gagea M; Kundra V; Kim SJ; Newman RA; Yang P
    Invest New Drugs; 2015 Apr; 33(2):271-9. PubMed ID: 25476893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of oleandrin and PBI-05204 against bovine viruses of importance to commercial cattle health.
    Newman RA; Chase CCL; Matos JR; Abdelsalam K; Buterbaugh R; Van Holland S; Abdelaal H; Woolum A; Jagannadha Sastry K
    Antivir Chem Chemother; 2022; 30():20402066221103960. PubMed ID: 35611441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase II, Single-Arm, Open-Label, Bayesian Adaptive Efficacy and Safety Study of PBI-05204 in Patients with Stage IV Metastatic Pancreatic Adenocarcinoma.
    Roth MT; Cardin DB; Borazanci EH; Steinbach M; Picozzi VJ; Rosemury A; Wadlow RC; Newman RA; Berlin J
    Oncologist; 2020 Oct; 25(10):e1446-e1450. PubMed ID: 32452588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Activities of the Botanical Extract PBI-05204 and Oleandrin on Innate Immune Functions under Viral Challenge Versus Inflammatory Culture Conditions.
    Jensen GS; Yu L; Iloba I; Cruickshank D; Matos JR; Newman RA
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke.
    Van Kanegan MJ; Dunn DE; Kaltenbach LS; Shah B; He DN; McCoy DD; Yang P; Peng J; Shen L; Du L; Cichewicz RH; Newman RA; Lo DC
    Sci Rep; 2016 May; 6():25626. PubMed ID: 27172999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BDNF mediates neuroprotection against oxygen-glucose deprivation by the cardiac glycoside oleandrin.
    Van Kanegan MJ; He DN; Dunn DE; Yang P; Newman RA; West AE; Lo DC
    J Neurosci; 2014 Jan; 34(3):963-8. PubMed ID: 24431454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-human study of pbi-05204, an oleander-derived inhibitor of akt, fgf-2, nf-κΒ and p70s6k, in patients with advanced solid tumors.
    Hong DS; Henary H; Falchook GS; Naing A; Fu S; Moulder S; Wheler JJ; Tsimberidou A; Durand JB; Khan R; Yang P; Johansen M; Newman RA; Kurzrock R
    Invest New Drugs; 2014 Dec; 32(6):1204-12. PubMed ID: 24919855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.
    Festuccia C; Mancini A; Colapietro A; Gravina GL; Vitale F; Marampon F; Delle Monache S; Pompili S; Cristiano L; Vetuschi A; Tombolini V; Chen Y; Mehrling T
    J Hematol Oncol; 2018 Feb; 11(1):32. PubMed ID: 29486795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of radiosensitivity by the novel anticancer quinolone derivative vosaroxin in preclinical glioblastoma models.
    Gravina GL; Mancini A; Mattei C; Vitale F; Marampon F; Colapietro A; Rossi G; Ventura L; Vetuschi A; Di Cesare E; Fox JA; Festuccia C
    Oncotarget; 2017 May; 8(18):29865-29886. PubMed ID: 28415741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The small molecule drug CBL0137 increases the level of DNA damage and the efficacy of radiotherapy for glioblastoma.
    Tallman MM; Zalenski AA; Deighen AM; Schrock MS; Mortach S; Grubb TM; Kastury PS; Huntoon K; Summers MK; Venere M
    Cancer Lett; 2021 Feb; 499():232-242. PubMed ID: 33253788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MSI1 associates glioblastoma radioresistance via homologous recombination repair, tumor invasion and cancer stem-like cell properties.
    Lin JC; Tsai JT; Chao TY; Ma HI; Chien CS; Liu WH
    Radiother Oncol; 2018 Nov; 129(2):352-363. PubMed ID: 30322656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of Clinical Success and Molecular Mechanisms of Action of Novel Anti-glioblastoma Drugs: A Review.
    Abdullaeva S; Chubarev V; Valeeva A; Preferanskaya N; Neganova M; Smolyarchuk E; Liu J; Sukocheva O; Samsonov M; Alyautdin R
    Curr Med Chem; 2024 Jan; ():. PubMed ID: 38299393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor cell-targeting radiotherapy in the treatment of glioblastoma multiforme using linear accelerators.
    Chiang CS; Shih IJ; Shueng PW; Kao M; Zhang LW; Chen SF; Chen MH; Liu TY
    Acta Biomater; 2021 Apr; 125():300-311. PubMed ID: 33609743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.